Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal

Pharmaceutical giants have recently shown new enthusiasm for mental-health treatments with vast but unrealized promise.

Leave a Reply

Your email address will not be published. Required fields are marked *